Categories: Market Research

Mycoplasma Testing Market Forecast 2024-2033: Growth Rate, Drivers, And Trends|Abbott Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., Boston Scientific Corporation, Olympus Corporation,

The Mycoplasma Testing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Mycoplasma Testing Market:
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

According to The Business Research Company’s Mycoplasma Testing Global Market Report 2024, The mycoplasma testing market size has grown rapidly in recent years. It will grow from $0.94 billion in 2023 to $1.08 billion in 2024 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to outbreaks and contamination incidents, increased awareness, biotechnology sector expansion, research and development initiatives, healthcare industry trends, rise in cell culture production.

The mycoplasma testing market size is expected to see rapid growth in the next few years. It will grow to $1.71 billion in 2028 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to demand for quality assurance, emerging market demand, biopharmaceutical industry growth, rise in cell-based therapies, expansion of biotechnology sector. Major trends in the forecast period include regulatory standards and compliance, healthcare awareness and diagnostics, global pandemic preparedness, point-of-care testing innovation, market penetration in emerging economies.

The increasing prevalence of mycoplasma pneumonia is expected to propel the growth of the mycoplasma testing market going forward. Mycoplasma pneumonia refers to a respiratory infection caused by the bacteria Mycoplasma pneumoniae. Mycoplasma testing plays a crucial role in diagnosing Mycoplasma pneumonia by detecting the presence of Mycoplasma pneumoniae bacteria in respiratory specimens, aiding in the timely and accurate identification of the infection for appropriate medical treatment and management. For instance, in December 2023, according to the Centers for Disease Control and Prevention, a US-based government agency An estimated 2 million cases of Mycoplasma pneumoniae infections occur each year in the United States. Therefore, the increasing prevalence of mycoplasma pneumonia is driving the growth of the mycoplasma testing market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp

The mycoplasma testing market covered in this report is segmented –

1) By Product: Instruments, Assay, Kits, and Reagents
2) By Technology: PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies
3) By Application: Cell line Testing, Virus Testing, End- of- Production Cell Testing
4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes

Major companies operating in the mycoplasma testing market are increasing their focus on introducing digital PCR kits to gain a competitive edge in the market. Digital PCR kits refer to molecular biology tools that enable the precise quantification and analysis of nucleic acids, such as DNA or RNA, by using a digital approach. For instance, in November 2023, QIAGEN, a Germany-based diagnostics company, launched three new QIAcuity digital PCR kits and updated software to expand the use of digital PCR applications in biopharmaceutical research and food safety. The new QIAcuity kits are designed to ensure precise quantification and are available in one, four, and eight-plate versions, with the one-plate version capable of processing up to 384 samples in an eight-hour shift. The QIAcuity Mycoplasma Quant Kit is one of the new kits launched, and it offers researchers an accurate and precise way to detect mycoplasma contaminants in all steps of research.

The mycoplasma testing market report table of contents includes: